TabletAnti Cancer

Sorafenib Tosylate Tablets

Sorafenib Tosylate · Multikinase inhibitor antineoplastic

TabletAnti Cancer

Sorafenib Tosylate TabletsProspero Healthcare

A tablet containing sorafenib tosylate, an oral multikinase inhibitor. It is used in the treatment of advanced hepatocellular carcinoma and renal cell carcinoma.

Uses

Hepatocellular carcinoma
Renal cell carcinoma

Enquire about this product

Specifications are indicative; availability, composition, pack sizes and registration requirements may vary by destination market.

01Specification

Product details

Composition: Sorafenib Tosylate
Available strengthsIndicative: 200 mg
Dosage form: Tablet
Therapeutic category: Anti Cancer
Therapeutic class: Multikinase inhibitor antineoplastic
Packing: 10 × 10 tablets in blister / Alu-Alu strips
Storage: Store below 30 °C, protected from light and moisture.

02Related

From the same category

View the category

Injection
Gemcitabine Injection
Gemcitabine InjectionInjection
Injection
Methotrexate Injection
Methotrexate InjectionInjection
Tablet
Tamoxifen Tablets
Tamoxifen TabletsTablet
Tablet
Abiraterone Acetate Tablets
Abiraterone Acetate TabletsTablet
Tablet
Chlorambucil Tablets
Chlorambucil TabletsTablet
Injection
Daunorubicin Injection
Daunorubicin InjectionInjection